Comparing Clinical Efficacy of C5, C3 and Factor B Inhibition in Paroxysmal Nocturnal Hemoglobinuria
Bibliographic record
Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life-threatening hematologic disorder that is caused by unregulated complement activation, leading to chronic red blood cell (RBC) hemolysis, anemia, fatigue, and an increased risk of thrombosis. The therapeutic landscape for PNH includes three key complement-targeting agents: ravulizumab (C5 inhibitor), pegcetacoplan (C3 inhibitor), and iptacopan (factor B inhibitor), each acting at different points in the complement cascade and demonstrating variable clinical efficacy. This study evaluates each treatment’s clinical effectiveness through a comparative analysis of six pivotal phase III trials, integrating primary and key secondary endpoints as well as commonly reported PNH biomarkers. The analysis encompasses both treatment-naïve patients and those transitioning between complement inhibitors. Findings suggest that factor B inhibition provides the most robust overall clinical efficacy, while C3 inhibition offers superior protection against hemolysis by blocking complement activation at an earlier stage. Although C5 inhibition remains a viable treatment option, it is associated with a higher likelihood of breakthrough hemolysis. However, limitations of this comparison of pivotal phase III trials include: heterogeneity in patient baseline characteristics, differences in trial design, variability in endpoint selection, and discrepancies in biomarker reporting. Ultimately, this work demonstrates the need for a greater understanding of the complement cascade and the effects of its inhibition at different points of activation in relation to diseases, such as PNH, that arise from its dysregulation.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.006 | 0.002 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.002 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.001 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".